Openly accessible

Stress, inflammation, and cellular vulnerability during early stages of affective disorders: biomarker strategies and opportunities for prevention and intervention

Walker, Adam J., Kim, Yesul, Price, J. Blair, Kale, Rajas P., McGillivray, Jane A., Berk, Michael and Tye, Susannah J. 2014, Stress, inflammation, and cellular vulnerability during early stages of affective disorders: biomarker strategies and opportunities for prevention and intervention, Frontiers in psychiatry, vol. 5, no. 34.

Attached Files
Name Description MIMEType Size Downloads
walker-stressinflammation-2014.pdf Published version application/pdf 708.91KB 24

Title Stress, inflammation, and cellular vulnerability during early stages of affective disorders: biomarker strategies and opportunities for prevention and intervention
Author(s) Walker, Adam J.
Kim, Yesul
Price, J. Blair
Kale, Rajas P.
McGillivray, Jane A.
Berk, Michael
Tye, Susannah J.
Journal name Frontiers in psychiatry
Volume number 5
Issue number 34
Total pages 8
Publisher Frontiers Research Foundation
Place of publication Lausanne, Switzerland
Publication date 2014-04
ISSN 1664-0640
Keyword(s) prodrome
depression
bipolar
biomarker
stress
inflammation
cellular resilience
plasticity
Summary The mood disorder prodrome is conceptualized as a symptomatic, but not yet clinically diagnosable stage of an affective disorder. Although a growing area, more focused research is needed in the pediatric population to better characterize psychopathological symptoms and biological markers that can reliably identify this very early stage in the evolution of mood disorder pathology. Such information will facilitate early prevention and intervention, which has the potential to affect a person’s disease course.This review focuses on the prodromal characteristics, risk factors, and neurobiological mechanisms of mood disorders. In particular, we consider the influence of early-life stress, inflammation, and allostatic load in mediating neural mechanisms of neuroprogression. These inherently modifiable factors have known neuroadaptive and neurodegenerative implications, and consequently may provide useful biomarker targets. Identification of these factors early in the course of the disease will accordingly allow for the introduction of early interventions which augment an individual’s capacity for psychological resilience through maintenance of synaptic integrity and cellular resilience. A targeted and complementary approach to boosting both psychological and physiological resilience simultaneously during the prodromal stage of mood disorder pathology has the greatest promise for optimizing the neurodevelopmental potential of those individuals at risk of disabling mood disorders.
Language eng
Field of Research 170101 Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology)
Socio Economic Objective 920410 Mental Health
HERDC Research category C3 Non-refereed articles in a professional journal
Copyright notice ©2014, Frontiers Research Foundation
Persistent URL http://hdl.handle.net/10536/DRO/DU:30062484

Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.

Versions
Version Filter Type
Access Statistics: 90 Abstract Views, 24 File Downloads  -  Detailed Statistics
Created: Tue, 15 Apr 2014, 15:41:25 EST by Jane Moschetti

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.